期刊
CRYSTAL GROWTH & DESIGN
卷 14, 期 5, 页码 2192-2200出版社
AMER CHEMICAL SOC
DOI: 10.1021/cg401708s
关键词
-
资金
- EPSKC, UK - DTA awards [EP/P504953/1, EP/P505550/1]
- EPSKC, UK - Platform Grant award [EP/J014974/1]
- Pharmacat Consortium
- EPSRC [EP/J014974/1] Funding Source: UKRI
- Engineering and Physical Sciences Research Council [EP/J014974/1] Funding Source: researchfish
Organic solvent nanofiltration (OSN) is suggested as a method for enhancing crystallization in the pharmaceutical industry. OSN crystallization has the potential to reduce energy and/or chemical inputs and allows for control of process conditions and crystal morphology. This work focuses on the crystallization of the pharmaceutical compound griseofulvin using OSN membranes to concentrate solutions via solvent removal. Griseofulvin solutions were concentrated in a pressure-driven dead-end nanofiltration cell, and crystals were allowed to spontaneously nucleate. The process was carried out using a range of different pressures to manipulate the solvent flux through the membrane. It was found that two distinct crystal types could be produced by altering the process solvent flux. At high flux, large crystals (approximate to 1 mm) were produced, whereas, at low flux, small crystals (2-25 mu m), which grew in clustered formations, were observed. The large crystals produced a previously unreported X-ray powder diffraction pattern, suggesting a slightly different morphology of griseofulvin than that resulting from traditional crystallization methods. The difference in crystallization morphologies could be attributed to the effect of preferential surface and bulk phase crystal nucleation and growth. The precise control of process conditions afforded by OSN crystallization might lead to rapid discovery of new morphologies of pharmaceutical compounds.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据